Waters Corp raises annual profit forecast on higher demand for lab equipment
Nov 1 (Reuters) -Waters Corp WAT.N raised its annual profit forecast after beating Wall Street estimates for third-quarterprofit and revenue on Friday, on improved demand for its products and services used in drug development and research.
The lab equipment and software maker expects its 2024 adjusted profit to be between $11.67 and $11.87 per share, compared with its prior forecast of $11.55 to $11.65 per share. Analysts were expecting $11.60, according to LSEG data.
Waters now expects its annual revenue to decline by 0.2% to 0.8%, versus its previous outlook of a 0.7% to 2.2% decline.
The earnings were driven by new product adoption and improved consumer spending trends, said CEO Udit Batra.
Lab equipment makers have been witnessing reduced spending from biotechs since last year, but recent interest-rate cuts could improve the funding environment for such clients as borrowing costs might ease.
Milford, Massachusetts-based Waters supplies lab equipment and technology for scientists across the world, with the majority of its revenue coming in from biopharma clients who use its tools for research and drug development.
Larger peer Thermo Fisher Scientific TMO.N raised the lower end of its annual profit forecast last month, betting on improved demand for its tools and services used in drug development.
Waters also forecast fourth-quarter adjusted per share profit at $3.90 to $4.10. Analysts on average expect it to be $4.09.
Its third-quarter revenue grew 4% to $740.3 million, ahead of analysts' estimate of $713 million. The company posted an adjusted profit per share of $2.93, beating estimates of $2.68.
Reporting by Puyaan Singh in Bengaluru; Editing by Shilpi Majumdar
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
